These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


203 related items for PubMed ID: 8074453

  • 41. Survivin is associated with cell proliferation and has a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer.
    Koike H, Morikawa Y, Sekine Y, Matsui H, Shibata Y, Suzuki K.
    J Urol; 2011 Apr; 185(4):1497-503. PubMed ID: 21334676
    [Abstract] [Full Text] [Related]

  • 42. Expression and vitamin D3 regulation of long-chain fatty-acid-CoA ligase 3 in human prostate cancer cells.
    Qiao S, Tuohimaa P.
    Prostaglandins Leukot Essent Fatty Acids; 2011 Apr; 84(1-2):19-23. PubMed ID: 21041072
    [Abstract] [Full Text] [Related]

  • 43. A low-calcemic vitamin D analog (Ro 25-4020) inhibits the growth of LNCaP human prostate cancer cells with increased potency by producing an active 24-oxo metabolite (Ro 29-9970).
    Swami S, Zhao XY, Sarabia S, Siu-Caldera ML, Uskokovic M, Reddy SG, Feldman D.
    Recent Results Cancer Res; 2003 Apr; 164():349-52. PubMed ID: 12899533
    [Abstract] [Full Text] [Related]

  • 44. The novel vitamin D analog ZK191784 inhibits prostate cancer cell invasion.
    Stio M, Martinesi M, Simoni A, Zuegel U, Steinmeyer A, Santi R, Treves C, Nesi G.
    Anticancer Res; 2011 Dec; 31(12):4091-8. PubMed ID: 22199266
    [Abstract] [Full Text] [Related]

  • 45. Luminal and humoral influences on human rectal epithelial cytokinetics.
    Thomas MG.
    Ann R Coll Surg Engl; 1995 Mar; 77(2):85-9. PubMed ID: 7793821
    [Abstract] [Full Text] [Related]

  • 46. Antiproliferative role of vitamin D and its analogs--a brief overview.
    Banerjee P, Chatterjee M.
    Mol Cell Biochem; 2003 Nov; 253(1-2):247-54. PubMed ID: 14619976
    [Abstract] [Full Text] [Related]

  • 47. 1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration.
    Sung V, Feldman D.
    Mol Cell Endocrinol; 2000 Jun; 164(1-2):133-43. PubMed ID: 11026565
    [Abstract] [Full Text] [Related]

  • 48. ANTIPROLIFERATIVE AND CYTOTOXIC EFFECT OF SELECTED VITAMIN D ANALOGS ON NASAL POLYPS FIBROBLASTS AND OTHER CELLS WITH HIGHER PROLIFERATIVE POTENTIAL.
    Frączek M, Kuśmierz D, Rostkowska-Nadolska B, Kutner A, Latocha MT.
    Acta Pol Pharm; 2015 Jun; 72(5):923-9. PubMed ID: 26665399
    [Abstract] [Full Text] [Related]

  • 49. Remodeling of phospholipid composition in colon cancer cells by 1α,25(OH)2D3 and its analogs.
    Leyssens C, Marien E, Verlinden L, Derua R, Waelkens E, Swinnen JV, Verstuyf A.
    J Steroid Biochem Mol Biol; 2015 Apr; 148():172-8. PubMed ID: 25625664
    [Abstract] [Full Text] [Related]

  • 50. Vitamin D and prostate cancer.
    Blutt SE, Weigel NL.
    Proc Soc Exp Biol Med; 1999 Jun; 221(2):89-98. PubMed ID: 10352118
    [Abstract] [Full Text] [Related]

  • 51. Pathways mediating the growth-inhibitory actions of vitamin D in prostate cancer.
    Peehl DM, Krishnan AV, Feldman D.
    J Nutr; 2003 Jul; 133(7 Suppl):2461S-2469S. PubMed ID: 12840225
    [Abstract] [Full Text] [Related]

  • 52. Genistein and vitamin D synergistically inhibit human prostatic epithelial cell growth.
    Rao A, Woodruff RD, Wade WN, Kute TE, Cramer SD.
    J Nutr; 2002 Oct; 132(10):3191-4. PubMed ID: 12368417
    [Abstract] [Full Text] [Related]

  • 53. GADD45gamma: a new vitamin D-regulated gene that is antiproliferative in prostate cancer cells.
    Flores O, Burnstein KL.
    Endocrinology; 2010 Oct; 151(10):4654-64. PubMed ID: 20739400
    [Abstract] [Full Text] [Related]

  • 54. Vitamin D and prostate cancer.
    Feldman D, Skowronski RJ, Peehl DM.
    Adv Exp Med Biol; 1995 Oct; 375():53-63. PubMed ID: 7645428
    [Abstract] [Full Text] [Related]

  • 55. The antiproliferative effect of vitamin D analogs on MCF-7 human breast cancer cells.
    Brenner RV, Shabahang M, Schumaker LM, Nauta RJ, Uskokovic MR, Evans SR, Buras RR.
    Cancer Lett; 1995 May 25; 92(1):77-82. PubMed ID: 7757962
    [Abstract] [Full Text] [Related]

  • 56. Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analogue EB 1089 in prostate cancer cells.
    Peehl DM, Seto E, Hsu JY, Feldman D.
    J Urol; 2002 Oct 25; 168(4 Pt 1):1583-8. PubMed ID: 12352462
    [Abstract] [Full Text] [Related]

  • 57. 1alpha,25-Dihydroxyvitamin D3 enhances proliferation of rat prostate cancer cells in the presence of living bone.
    Herring PA, Ingels J, Palmieri G, Hasty KA.
    J Steroid Biochem Mol Biol; 2007 Mar 25; 103(3-5):737-41. PubMed ID: 17210249
    [Abstract] [Full Text] [Related]

  • 58. 1alpha,25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha,25(OH)(2)D(2), potentiate the effects of ionising radiation on human prostate cancer cells.
    Dunlap N, Schwartz GG, Eads D, Cramer SD, Sherk AB, John V, Koumenis C.
    Br J Cancer; 2003 Aug 18; 89(4):746-53. PubMed ID: 12915889
    [Abstract] [Full Text] [Related]

  • 59. Vitamin D analogs and breast cancer.
    O'Kelly J, Koeffler HP.
    Recent Results Cancer Res; 2003 Aug 18; 164():333-48. PubMed ID: 12899532
    [Abstract] [Full Text] [Related]

  • 60. Early growth inhibition is followed by increased metastatic disease with vitamin D (calcitriol) treatment in the TRAMP model of prostate cancer.
    Ajibade AA, Kirk JS, Karasik E, Gillard B, Moser MT, Johnson CS, Trump DL, Foster BA.
    PLoS One; 2014 Aug 18; 9(2):e89555. PubMed ID: 24586868
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.